Trump announces 100% chip tariff as Apple ups U.S. investment
Chandler Robinson, the Chief Executive Officer of Monopar Therapeutics (NASDAQ:MNPR), recently sold 33,334 shares of the company’s common stock. The shares were sold on April 2 at a weighted average price of $35 per share, amounting to a total transaction value of approximately $1.17 million. The sale comes amid a significant -25% decline in the stock price over the past week, though InvestingPro data shows the stock has delivered an impressive 840% return over the past year. Following this transaction, Robinson holds 822,255 shares in the company. The sale was part of a series of transactions executed by Tactic Pharma LLC, where Robinson holds a managerial position along with other members. With a current market capitalization of $177 million and analyst price targets ranging from $40 to $76, InvestingPro subscribers can access 8 additional key insights about MNPR’s valuation and financial health.
In other recent news, Monopar Therapeutics announced its fourth quarter and full-year 2024 financial results, leading Jones Trading to downgrade the stock from a Buy to a Hold rating. This decision reflects a recalibration of expectations based on the earnings report and adjusted timelines for key drug developments. Meanwhile, Piper Sandler initiated coverage of Monopar with an Overweight rating and set a price target of $76 per share, citing optimism about the potential of ALXN1840 for treating Wilson disease. Piper Sandler also highlighted Monopar’s ongoing work on a therapy targeting uPAR for solid tumors, indicating potential growth prospects for the company. In executive news, Monopar appointed Quan Vu as the new Chief Financial Officer, bringing extensive experience in corporate finance and strategy. Furthermore, Lavina Talukdar joined Monopar’s Board of Directors, bringing over two decades of experience in healthcare investments and financial strategy. These developments come as Monopar continues to advance its therapeutic programs and navigate the regulatory landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.